The Cooper Companies, Inc. (COO) vs 10x Genomics, Inc. (TXG)

A side-by-side comparison of The Cooper Companies, Inc. and 10x Genomics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — COO vs TXG

growth of $100 · dividends reinvested · last 7y
COO -24.8% (-4.0%/yr)TXG +85.3% (+9.2%/yr)TXG compounded faster over this window
0100200300400Start $100202120232025$75$185
COO TXG

COO vs TXG: by the numbers

  • •COO is the larger company ($11.01B vs $10.24B market cap).
  • •COO is profitable (13.46% net margin) while TXG runs a net loss (-12.18%).
  • •TXG grew revenue faster over the past five years (8.74% vs 8.29% CAGR).

Metrics side by side

Valuation

MetricCOOTXG
P/E ratio19.26N/A
Forward P/E12.42N/A
P/S ratio2.6016.60
P/B ratio1.3212.40
EV / EBITDA14.43N/A
FCF yield6.16%1.19%

Profitability

MetricCOOTXG
Gross margin63.64%70.03%
Operating margin12.85%-14.33%
Net margin13.46%-12.18%
ROE6.85%-9.10%
ROIC4.76%-9.57%

Growth (annualized)

MetricCOOTXG
Revenue CAGR (5Y)8.29%8.74%
EPS CAGR (5Y)-17.30%N/A
FCF CAGR (5Y)5.21%N/A
Total return CAGR (5Y)-11.45%-7.24%

Frequently asked

Which has grown faster, COO or TXG?
Over the past five years, TXG grew revenue faster — COO at a 8.29% CAGR versus TXG at 8.74%.
Is COO or TXG more profitable?
COO runs the higher net margin — COO at 13.46% versus TXG at -12.18%.
How have COO and TXG total returns compared?
Over the past 5 years, COO delivered -11.45% and TXG delivered -7.24% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.